Shin Nippon Biomedical Laboratories, Ltd. (JP:2395) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Shin Nippon Biomedical Laboratories reported a 5.3% increase in revenue for the six months ending September 2024, reaching 12,508 million yen, despite a significant drop in operating profit by 96.6%. The company’s net assets grew to 36,453 million yen, although the equity ratio decreased to 40.9%. Dividends for the fiscal year are forecasted to remain stable at 50 yen per share.
For further insights into JP:2395 stock, check out TipRanks’ Stock Analysis page.